Assessing developability early in the discovery process for novel biologics
ABSTRACTBeyond potency, a good developability profile is a key attribute of a biological drug. Selecting and screening for such attributes early in the drug development process can save resources and avoid costly late-stage failures. Here, we review some of the most important developability properti...
Saved in:
Main Authors: | Monica L. Fernández-Quintero (Author), Anne Ljungars (Author), Franz Waibl (Author), Victor Greiff (Author), Jan Terje Andersen (Author), Torleif T. Gjølberg (Author), Timothy P. Jenkins (Author), Bjørn Gunnar Voldborg (Author), Lise Marie Grav (Author), Sandeep Kumar (Author), Guy Georges (Author), Hubert Kettenberger (Author), Klaus R. Liedl (Author), Peter M. Tessier (Author), John McCafferty (Author), Andreas H. Laustsen (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
20 More Selected Stories from Drue Heinz Literature Prize Winners, 2001-2021
by: McCafferty, Jane
Published: (2021) -
Asteroid Hyalosis: A Mimicker of Vitreous Hemorrhage on Point of Care Ultrasound: A Case Report
by: Eniola Gros, et al.
Published: (2023) -
Challenges in antibody structure prediction
by: Monica L. Fernández-Quintero, et al.
Published: (2023) -
Clinicians' perspectives of immersive tools in clinical mental health settings: a systematic scoping review
by: Jessica Cushnan, et al.
Published: (2024) -
Ensembles in solution as a new paradigm for antibody structure prediction and design
by: Monica L. Fernández-Quintero, et al.
Published: (2021)